FDA Inspection
Procter & Gamble Manufactura S. de R.L. de C.V.Procter & Gamble Manufactura S. de R.L. de C.V. – FDA Inspection, Jun 27, 2025
Record Details
This FDA Inspection record concerns Procter & Gamble Manufactura S. de R.L. de C.V., with an inspection on June 27, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- June 27, 2025
- Product Type
- Human Drugs
View Company Profile
ID · c8b6223b-77fe-41ca-88f1-7d33564caa09
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1275297
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.188(b)(11)Identification of Persons Performing Significant Steps
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Procter & Gamble Manufactura S. de R.L. de C.V.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 15, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 6, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Procter & Gamble Manufactura S. de R.L. de C.V.
- FDA Inspection 1055804 - 2018-06-15
- FDA Inspection 922870 - 2015-03-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.